Cancer Gene Therapy Market size to exceed $4.3bn by 2024: Global Market Insights Inc.
September 13, 2016 07:00 ET | Global Market Insights
Ocean View, Delaware, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Cancer Gene Therapy Market size was USD 805.5 million in 2015, with 20.7% CAGR estimation from 2016 to 2024; as per a new research report...
Genelux Corporation Presents Abstracts at 2013 ASCO Annual Meeting for Clinical Trials of GL-ONC1, Its Oncolytic Virus Lead Product Candidate
May 30, 2013 07:30 ET | Genelux Corporation
SAN DIEGO, CA--(Marketwired - May 30, 2013) - Genelux Corporation, a clinical-stage biopharmaceutical company that develops vaccinia virus-based cancer therapies and companion diagnostics, today...
Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients
June 28, 2012 11:00 ET | Genelux Corporation
SAN DIEGO, CA--(Marketwire - Jun 28, 2012) - Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based oncolytic (cancer-killing) therapies and companion...